Related Experiment Video
Updated: Nov 20, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota
Abbas Hatim Rupawala1, Darrel Gachette2, Mena Bakhit3
1Division of Gastroenterology, Department of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Abstract:
We evaluated serial fecal microbiota transplant (FMT) by retention enema in patients with severe or severe/complicated Clostridoides difficile infection (CDI) unresponsive to at least 48 hours of standard antibiotic therapy. Of the 15 patients included, despite initial improvement in most patients, only 5 patients sustained cure at 30 days, and serious adverse events occurred in 4 patients.
Insights
Serial fecal microbiota transplant (FMT) via retention enema showed limited sustained cure for severe Clostridoides difficile infection (CDI). While many patients improved initially, only 5 of 15 achieved a 30-day cure, with 4 experiencing serious adverse events.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Microbiology
Background:
- Clostridoides difficile infection (CDI) poses a significant challenge, particularly severe or complicated cases unresponsive to standard antibiotic therapy.
- Recurrent CDI necessitates exploring alternative and effective treatment strategies.
Purpose of the Study:
- To evaluate the efficacy and safety of serial fecal microbiota transplant (FMT) administered via retention enema for patients with refractory severe or severe/complicated CDI.
Main Methods:
- A cohort of 15 patients with severe/complicated CDI, failing at least 48 hours of antibiotics, received serial FMT by retention enema.
- Patient outcomes, including sustained cure at 30 days and adverse events, were monitored.
Main Results:
- Initial clinical improvement was observed in the majority of patients following FMT.
- However, only 5 out of 15 patients achieved a sustained cure at the 30-day follow-up.
- Four patients experienced serious adverse events during the study period.
Conclusions:
- Serial FMT via retention enema demonstrates potential for initial symptom relief in severe CDI.
- The treatment shows limited efficacy in achieving sustained cure rates at 30 days for this patient population.
- Further research is warranted to optimize FMT protocols and assess long-term safety for refractory CDI.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Ulcerative Colitis in IBD

